Ulotaront is a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity.
Your search for major depressive disorder returned 3 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.